CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer
Hao Liu, Mazen S. Zenati, Caroline J. Rieser, Amr I. Al Abbas, Kenneth K. Lee, Aatur D. Singhi, Nathan Bahary, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat
Topics & Concepts
MedicinePancreatic cancerNatInternal medicineProportional hazards modelNeoadjuvant therapyAdjuvant therapyHazard ratioOncologyCohortCA19-9GastroenterologyCancerBreast cancerComputer scienceConfidence intervalComputer networkPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies